Ziegelhöffer A, Ravingerová T, Dzurba A, Tribulová N, Slezák J, Breier A, Szekeres L
Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovak Republic.
Mol Cell Biochem. 1996 Jul-Aug;160-161:257-63. doi: 10.1007/BF00240057.
It is demonstrated a fast and significant depression in the sarcolemmal (Na,K)-ATPase activity that occurs as early as 25 sec after the onset of Ca2+ depletion, and participates in the development of Ca(2+)-paradox in the rat heart. Pretreatment of the animals with 7-oxo-prostacyclin (PGI2) 24-48 h prior to the experiment prevented fairly the Ca(2+)-depletion-induced depression in (Na,K)ATPase activity and the accompanying structural and functional damage to the heart and sarcolemma during Ca(2+)-depletion as well as the development of Ca(2+)-paradox during the subsequent Ca(2+)-repletion. Pretreatment with PGI2 was chosen intentionally because previous experiments revealed, that in its late effect the drug is acting via stabilizing the membranes due induction of high activity of (Na,K)-ATPase that has increased affinity to ATP. From results obtained the following may be concluded: If during the phase of Ca(2+)-deprivation, the capability of heart sarcolemma to maintain sodium extrusion remains preserved, the expected aggravation of Ca(2+)-overload injury to Ca(2+)-paradox that would develop during Ca(2+)-repletion, may be definitely prevented. Sufficiently preserved (Na,K)-ATPase activity, hand in hand with stabilized sarcolemmal structure, may prevent an accumulation of sodium beneath the sarcolemma and consequently also an overexcessive entry of Ca2+ into the myocytes.
结果表明,早在钙耗竭开始后25秒,肌膜(钠,钾)-ATP酶活性就会迅速且显著降低,这参与了大鼠心脏钙(2+)矛盾现象的发展。在实验前24-48小时用7-氧代前列环素(PGI2)对动物进行预处理,相当程度上预防了钙(2+)耗竭诱导的(钠,钾)-ATP酶活性降低,以及在钙(2+)耗竭期间伴随的心脏和肌膜结构与功能损伤,以及随后钙(2+)再灌注期间钙(2+)矛盾现象的发展。选择PGI2预处理是有意为之,因为先前的实验表明,该药物的后期作用是通过诱导对ATP亲和力增加的(钠,钾)-ATP酶高活性来稳定膜。从获得的结果可以得出以下结论:如果在钙(2+)剥夺阶段,心脏肌膜维持钠排出的能力得以保留,那么在钙(2+)再灌注期间可能发展的钙(2+)矛盾现象中预期的钙(2+)过载损伤加重肯定可以预防。足够保留的(钠,钾)-ATP酶活性与稳定的肌膜结构一起,可以防止钠在肌膜下积聚,从而也防止过多的钙2+进入心肌细胞。